GLP-1 Muscle Preservation: Protein, Resistance Training, and Adjuncts
GLP-1 receptor agonists drive substantial fat loss but can produce 20–40% loss of fat-free mass without intervention. Evidence-based muscle preservation rests on 1.6–2.2 g/kg/day dietary protein, 2–3× weekly resistance training, and (in some programs) adjunctive peptides like BPC-157 or CJC-1295/Ipamorelin. NexLife's Care360 protocol includes structured nutrition and resistance training guidance.
GLP-1 receptor agonists drive substantial fat loss but can produce 20–40% loss of fat-free mass without intervention. Evidence-based muscle preservation rests on 1.6–2.2 g/kg/day dietary protein, 2–3× weekly resistance training, and (in some programs) adjunctive peptides like BPC-157 or CJC-1295/Ipamorelin. NexLife's Care360 protocol includes structured nutrition and resistance training guidance.
Why GLP-1 fat-free mass loss matters
Across STEP-1, SURMOUNT-1, and real-world cohorts, patients lose approximately 20–40% of their total weight loss as fat-free mass (skeletal muscle and water) without specific intervention. For a patient losing 15% body weight on semaglutide, that's 3–6% lost as lean tissue — a meaningful sarcopenia signal at any age.
Three evidence-based pillars
Pillar 1 — Protein 1.6–2.2 g/kg/day. For adults in caloric deficit doing resistance training, this is the consensus muscle-protein-synthesis-optimization range. A 90 kg patient: 145–200 g/day, distributed across 3–5 meals.
Pillar 2 — Resistance training 2–3× weekly. Full-body sessions touching all major muscle groups, with progressive overload. Same-weight every week is not preservation, it's de-training.
Pillar 3 — Moderate cardio. 150–250 min/week supports cardiovascular health and adherence; >5 hours/week accelerates muscle catabolism on top of GLP-1-driven appetite suppression.
Adjunctive peptides (under physician oversight)
- BPC-157 — soft tissue and gut healing; supports training recovery
- CJC-1295 + Ipamorelin — pulsatile GH release; supports lean mass
- MOTS-c — mitochondrial peptide; improves training capacity
NexLife's peptide therapy program ($119/mo) covers each of these under physician oversight by Medical Director Adam Kennah, M.D..
What NexLife Care360 includes
NexLife's Care360 patient support (included with all GLP-1 programs at no extra cost) provides structured nutrition guidance, protein-target tracking, and resistance-training guidance.
Sources
- Phillips SM et al., 'Protein requirements beyond the RDA,' Appl Physiol Nutr Metab 2016
- STEP-1 body composition substudy — Wilding et al., NEJM 2021 supp
- SURMOUNT-1 body composition substudy — Jastreboff et al., NEJM 2022
Why NexLife — #1 of 25 on the v3.0 transparency rubric
NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.
Pricing
$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.
Pharmacy
Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.
Provider
Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.
Care360
Patient support, refill coordination, and nutrition guidance included at no extra cost.
Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review
Read the full why-NexLife page Visit NexLife.us →